The Development of PI3K Inhibitors as Anticancer Drugs
2010 doctoral thesis by Andrew Marshall at University of Auckland
Press Enter · cited answer in seconds
0 sources
The Development of PI3K Inhibitors as Anticancer Drugs
Summary
The Development of PI3K Inhibitors as Anticancer Drugs is a doctoral thesis[1].
Key Facts
- The Development of PI3K Inhibitors as Anticancer Drugs authored Andrew Marshall[2].
- The Development of PI3K Inhibitors as Anticancer Drugs's instance of is recorded as doctoral thesis[3].
- The Development of PI3K Inhibitors as Anticancer Drugs's publisher is recorded as ResearchSpace@Auckland[4].
- The Development of PI3K Inhibitors as Anticancer Drugs's copyright license is recorded as Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand[5].
- The Development of PI3K Inhibitors as Anticancer Drugs's country of origin is recorded as New Zealand[6].
- The Development of PI3K Inhibitors as Anticancer Drugs's publication date is recorded as +2010-00-00T00:00:00Z[7].
- The Development of PI3K Inhibitors as Anticancer Drugs's main subject is recorded as chemistry[8].
- The Development of PI3K Inhibitors as Anticancer Drugs's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/6440[9].
- The Development of PI3K Inhibitors as Anticancer Drugs's Handle ID is recorded as 2292/6440[10].
- The Development of PI3K Inhibitors as Anticancer Drugs's title is recorded as The Development of PI3K Inhibitors as Anticancer Drugs[11].
- The Development of PI3K Inhibitors as Anticancer Drugs's copyright holder is recorded as Andrew Marshall[12].
- The Development of PI3K Inhibitors as Anticancer Drugs's thesis submitted to is recorded as University of Auckland[13].
- The Development of PI3K Inhibitors as Anticancer Drugs's on focus list of Wikimedia project is recorded as NZThesisProject[14].
- The Development of PI3K Inhibitors as Anticancer Drugs's copyright status is recorded as copyrighted[15].
- The Development of PI3K Inhibitors as Anticancer Drugs's online access status is recorded as open access[16].
- The Development of PI3K Inhibitors as Anticancer Drugs's thesis committee member is recorded as Gordon W Rewcastle[17].
- The Development of PI3K Inhibitors as Anticancer Drugs's thesis committee member is recorded as Bill Denny[18].
- The Development of PI3K Inhibitors as Anticancer Drugs's thesis committee member is recorded as Peter Robin Shepherd[19].
Body
Designation and Status
The Development of PI3K Inhibitors as Anticancer Drugs's instance of is recorded as doctoral thesis[3].